It was hard to miss the headlines out of the recent American College of Cardiology meeting in Chicago: Vytorin, the blockbuster cholesterol drug combination from Merck and Schering-Plough, had ...

In recent years, Los Angeles’ city leadership has labored in an often harsh, unsettling spotlight, with epic problems roiling the metropolis. Attempts to focus on the burgeoning woes of ...